luminol has been researched along with Pneumonia, Viral in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Brysch, W; Fagone, P; Kaiser, A; Ludescher, B; Mangano, K; Nicoletti, F; Niedermaier, M; Rauch, P; Schubert, U; Schulz, P; Schumann, S; Setz, C; van Wijk, E; von Wegerer, J; Yan, Y | 1 |
1 other study(ies) available for luminol and Pneumonia, Viral
Article | Year |
---|---|
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19.
Topics: Amination; Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Cytokines; Female; Humans; Immunologic Factors; Inflammation; Luminol; Male; Mice; Mice, Inbred C57BL; Pandemics; Pneumonia, Viral; Poly (ADP-Ribose) Polymerase-1; Reactive Oxygen Species; SARS-CoV-2; Vero Cells | 2020 |